Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alka Pharma S.r.l. is an Italian pharmaceutical company headquartered in Milan that specializes in the development and commercialization of health solutions for urology, gynecology, and gastroenterology. The company's portfolio includes a range of medical devices, food supplements, and pharmaceutical formulations designed to manage chronic and acute conditions like urinary tract infections and prostatic hypertrophy. Alka Pharma focuses on evidence-based ingredients, such as D-mannose and Serenoa repens, to provide non-invasive therapeutic options for patients. Their business model relies on strong relationships with specialist medical practitioners and a robust distribution network within the Italian healthcare market. As a commercial-stage entity, they emphasize high-quality manufacturing standards and clinical validation for their specialized product lines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alka Pharma.